Atrium Therapeutics, Inc.
RNA
$13.19
$0.413.21%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -- | -- | |||
| Total Receivables | -- | -- | |||
| Inventory | -- | -- | |||
| Prepaid Expenses | -- | 217.81% | |||
| Finance Division Loans and Leases Current | -- | -- | |||
| Total Finance Division Other Current Assets | -- | -- | |||
| Other Current Assets | -- | -- | |||
| Total Current Assets | -- | 489.03% | |||
|
|
|||||
| Total Current Assets | -- | 489.03% | |||
| Net Property, Plant & Equipment | -- | -17.83% | |||
| Long-term Investments | -- | -- | |||
| Goodwill | -- | -- | |||
| Total Other Intangibles | -- | -- | |||
| Finance Div Loans & Leases LT | -- | -- | |||
| Total Finance Div Other LT Assets | -- | -- | |||
| Total Other Assets | -- | -- | |||
| Total Assets | -- | 16.24% | |||
|
|
|||||
| Total Accounts Payable | -- | 726.69% | |||
| Total Accrued Expenses | -- | 504.03% | |||
| Short-term Debt | -- | -- | |||
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | |||
| Finance Division Debt Current | -- | -4.47% | |||
| Total Finance Division Other Current Liabilities | -- | 19.31% | |||
| Total Other Current Liabilities | -- | 19.31% | |||
| Total Current Liabilities | -- | 55.96% | |||
|
|
|||||
| Total Current Liabilities | -- | 55.96% | |||
| Long-Term Debt | -- | -- | |||
| Short-term Debt | -- | -- | |||
| Capital Leases | -- | -- | |||
| Finance Division Debt Non Current | -- | -- | |||
| Total Finance Division Other Non Current Liabilities | -- | -- | |||
| Total Other Liabilities | -- | -24.06% | |||
| Total Liabilities | -- | 4.06% | |||
|
|
|||||
| Common Stock & APIC | -- | -2.63% | |||
| Retained Earnings | -- | -- | |||
| Treasury Stock & Other | -- | -- | |||
| Total Common Equity | 483.10% | -2.63% | |||
|
|
|||||
| Preferred Stock Redeemable | -- | -- | |||
| Preferred Stock Non Redeemable | -- | -- | |||
| Preferred Stock Convertible | -- | -- | |||
| Preferred Stock, Others | -- | -- | |||
| Total Preferred Equity | -- | -- | |||
|
|
|||||
| Total Common Equity | 483.10% | -2.63% | |||
| Total Preferred Equity | -- | -- | |||
| Total Minority Interest | -- | -- | |||
| Total Equity | 483.10% | -2.63% | |||
|
|
|||||